Cytokinetics Up 9% (CYTK)

Cytokinetics, Inc. CYTK shares are significantly higher this morning, gaining 9% to $1.69, a gain of 14 cents on 27,000 shares so far this morning. Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!